Skip to main content
Erschienen in: Tumor Biology 3/2016

12.10.2015 | Original Article

Esculin and its oligomer fractions inhibit adhesion and migration of U87 glioblastoma cells and in vitro angiogenesis

verfasst von: Imen Mokdad-Bzeouich, Hervé Kovacic, Kamel Ghedira, Latifa Chebil, Mohamed Ghoul, Leila Chekir-Ghedira, José Luis

Erschienen in: Tumor Biology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Cancer metastasis is the major cause of cancer-related death. Chemoprevention is defined as the use of natural or synthetic substances to prevent cancer formation or cancer progress. In the present study, we investigate the antitumor activity of esculin and its oligomer fractions in U87 glioblastoma cells. We showed that esculin and its oligomers reduced U87 cell growth in a dose dependent manner. They also inhibited cell adhesion to collagen IV and vitronectin by interfering with the function of their respective receptors α2β1 and αvβ5 integrins. Furthermore, the tested samples were able to reduce migration of U87 cells towards another extracellular matrix fibronectin. Moreover, esculin and its oligomer fractions inhibited in vitro angiogenesis of endothelial cells (HMEC-1). In summary, our data provide the first evidence that esculin and its oligomer fractions are able to reduce adhesion, migration of glioblastoma cells and in vitro angiogenesis. Esculin and its oligomers may thus exert multi-target functions against cancer cells.
Literatur
1.
Zurück zum Zitat Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH. Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS One. 2010;5:12304.CrossRef Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH. Calcium-activated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS One. 2010;5:12304.CrossRef
2.
Zurück zum Zitat Nieder C, Astner ST, Mehta MP, Grosu AL, Molls M. Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma. Am J Clin Oncol. 2008;31:300–5.CrossRefPubMed Nieder C, Astner ST, Mehta MP, Grosu AL, Molls M. Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma. Am J Clin Oncol. 2008;31:300–5.CrossRefPubMed
3.
Zurück zum Zitat Zhang X, Zhang W, Cao WD, Cheng G, Zhang YQ. Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review). Exp Ther Med. 2012;3:9–14.PubMed Zhang X, Zhang W, Cao WD, Cheng G, Zhang YQ. Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review). Exp Ther Med. 2012;3:9–14.PubMed
4.
Zurück zum Zitat Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113:1953–68.CrossRefPubMedPubMedCentral Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113:1953–68.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62:753–64.CrossRefPubMed Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62:753–64.CrossRefPubMed
8.
Zurück zum Zitat Ong EB, Watanabe N, Saito A, Futamura Y, Abd El Galil KH, Koito A, et al. Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR. J Biol Chem. 2011;286:14049–56. Ong EB, Watanabe N, Saito A, Futamura Y, Abd El Galil KH, Koito A, et al. Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR. J Biol Chem. 2011;286:14049–56.
9.
Zurück zum Zitat Golfakhrabadi F, Abdollahi M, Ardakani MR, Saeidnia S, Akbarzadeh T, Ahmadabadi AN, et al. Anticoagulant activity of isolated coumarins (suberosin and suberenol)and toxicity evaluation of Ferulagocarduchorum in rats. Pharm Biol. 2014;52:1335–40. Golfakhrabadi F, Abdollahi M, Ardakani MR, Saeidnia S, Akbarzadeh T, Ahmadabadi AN, et al. Anticoagulant activity of isolated coumarins (suberosin and suberenol)and toxicity evaluation of Ferulagocarduchorum in rats. Pharm Biol. 2014;52:1335–40.
10.
Zurück zum Zitat Canning C, Sun S, Ji X, Gupta S, Zhou K. Antibacterial and cytotoxic activity of isoprenylated coumarin mammea A/AA isolated from Mammea africana. J Ethnopharmacol. 2013;147:259–62.CrossRefPubMed Canning C, Sun S, Ji X, Gupta S, Zhou K. Antibacterial and cytotoxic activity of isoprenylated coumarin mammea A/AA isolated from Mammea africana. J Ethnopharmacol. 2013;147:259–62.CrossRefPubMed
11.
Zurück zum Zitat Sashidhara KV, Rosaiah JN, Kumar A, Bhatia G, Khanna AK. Synthesis of novel benzocoumarin derivatives as lipid lowering agents. Bioorg Med Chem Lett. 2010;20:3065–9.CrossRefPubMed Sashidhara KV, Rosaiah JN, Kumar A, Bhatia G, Khanna AK. Synthesis of novel benzocoumarin derivatives as lipid lowering agents. Bioorg Med Chem Lett. 2010;20:3065–9.CrossRefPubMed
12.
Zurück zum Zitat Nasr T, Bondock S, Youns M. Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur J Med Chem. 2014;76:539–48.CrossRefPubMed Nasr T, Bondock S, Youns M. Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur J Med Chem. 2014;76:539–48.CrossRefPubMed
13.
Zurück zum Zitat Neelgundmath M, Dinesh KR, Mohan CD, Li F, Dai X, Siveen KS, et al. Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma. Bioorg Med Chem Lett. 2015;25:893–7. Neelgundmath M, Dinesh KR, Mohan CD, Li F, Dai X, Siveen KS, et al. Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma. Bioorg Med Chem Lett. 2015;25:893–7.
14.
Zurück zum Zitat Stefanova TH, Nikolova NJ, Toshkova RA, Neychev HO. Antitumor and immunomodulatory effect of coumarin and 7-hydroxycoumarin against Sarcoma 180 in mice. J Exp Ther Oncol. 2007;6:107–15.PubMed Stefanova TH, Nikolova NJ, Toshkova RA, Neychev HO. Antitumor and immunomodulatory effect of coumarin and 7-hydroxycoumarin against Sarcoma 180 in mice. J Exp Ther Oncol. 2007;6:107–15.PubMed
15.
Zurück zum Zitat Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicityin the human neuroblastoma SH-SY5Y cell line. Neuropharmacology. 2007;53:724–32.CrossRefPubMed Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicityin the human neuroblastoma SH-SY5Y cell line. Neuropharmacology. 2007;53:724–32.CrossRefPubMed
16.
Zurück zum Zitat Rios ER, Rocha NF, Venâncio ET, Moura BA, Feitosa ML, Cerqueira GS, et al. Mechanisms involved in the gastroprotective activity of esculin on acute gastric lesions in mice. Chem Biol Interact. 2010;188:246–54. Rios ER, Rocha NF, Venâncio ET, Moura BA, Feitosa ML, Cerqueira GS, et al. Mechanisms involved in the gastroprotective activity of esculin on acute gastric lesions in mice. Chem Biol Interact. 2010;188:246–54.
17.
Zurück zum Zitat Ben Rhouma G, Chebil L, Krifa M, Ghoul M, Chekir-Ghedira L. Evaluation of mutagenic and antimutagenic activities of oligorutin and oligoesculin. Food Chem. 2012;135:1700–7.CrossRefPubMed Ben Rhouma G, Chebil L, Krifa M, Ghoul M, Chekir-Ghedira L. Evaluation of mutagenic and antimutagenic activities of oligorutin and oligoesculin. Food Chem. 2012;135:1700–7.CrossRefPubMed
18.
Zurück zum Zitat Witaicenis A, Seito LN, da Silveira CA, de Almeida LD, Jr LAC, Rodrigues-Orsi P, et al. Antioxidant and intestinal anti inflammatory effects of plant-derived coumarin derivatives. Phytomedicine. 2014;21:240–6. Witaicenis A, Seito LN, da Silveira CA, de Almeida LD, Jr LAC, Rodrigues-Orsi P, et al. Antioxidant and intestinal anti inflammatory effects of plant-derived coumarin derivatives. Phytomedicine. 2014;21:240–6.
19.
Zurück zum Zitat Rahman MM. Evaluation of Hymenodictyon excelsum Phytochemical’s Therapeutic value against Prostate Cancer by Molecular Docking Study. Jundishapur J Nat Pharm Prod. 2015;10, e18216.CrossRefPubMedPubMedCentral Rahman MM. Evaluation of Hymenodictyon excelsum Phytochemical’s Therapeutic value against Prostate Cancer by Molecular Docking Study. Jundishapur J Nat Pharm Prod. 2015;10, e18216.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Pourroy B, Honoré S, Pasquier E, Bourgarel-Rey V, Kruczynski A, Briand C, et al. Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells. Cancer Res. 2006;66:3256–63. Pourroy B, Honoré S, Pasquier E, Bourgarel-Rey V, Kruczynski A, Briand C, et al. Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells. Cancer Res. 2006;66:3256–63.
21.
Zurück zum Zitat Rigot V, Lehmann M, Andre’ F, Daemi N, Marvaldi J, Luis J. Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J Cell Sci. 1998;111:3119–27.PubMed Rigot V, Lehmann M, Andre’ F, Daemi N, Marvaldi J, Luis J. Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J Cell Sci. 1998;111:3119–27.PubMed
22.
Zurück zum Zitat Kadi A, Pichard V, Lehmann M, Briand C, Braguer D, Marvaldi J, et al. Effect of microtubule disruption on cell adhesion and spreading. Biochem Biophys Res Comm. 1998;246:690–5. Kadi A, Pichard V, Lehmann M, Briand C, Braguer D, Marvaldi J, et al. Effect of microtubule disruption on cell adhesion and spreading. Biochem Biophys Res Comm. 1998;246:690–5.
23.
Zurück zum Zitat Morjen M, Kallech-Ziri O, Bazaa A, Othman H, Mabrouk K, Zouari-Kessentini R, et al. PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells. Matrix Biol. 2013;32:52–62. Morjen M, Kallech-Ziri O, Bazaa A, Othman H, Mabrouk K, Zouari-Kessentini R, et al. PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells. Matrix Biol. 2013;32:52–62.
24.
Zurück zum Zitat Pilorget A, Conesa M, Sarray S, Michaud-Levesque J, Daoud S, Kim KS, et al. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo. J Cell Physiol. 2007;211:307–15. Pilorget A, Conesa M, Sarray S, Michaud-Levesque J, Daoud S, Kim KS, et al. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo. J Cell Physiol. 2007;211:307–15.
25.
Zurück zum Zitat Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842–50.CrossRefPubMed Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842–50.CrossRefPubMed
26.
Zurück zum Zitat Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, Fair WR, et al. Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. Prostate. 1992;20:123–31. Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, Fair WR, et al. Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. Prostate. 1992;20:123–31.
27.
Zurück zum Zitat Thornes RD, Daly L, Lynch G, Breslin B, Browne H, Browne HY, et al. Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J Cancer Res Clin Oncol. 1994;120:32–4.CrossRef Thornes RD, Daly L, Lynch G, Breslin B, Browne H, Browne HY, et al. Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J Cancer Res Clin Oncol. 1994;120:32–4.CrossRef
28.
Zurück zum Zitat Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25:234–40.CrossRefPubMedPubMedCentral Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25:234–40.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Velasco-Velázquez MA, Agramonte-Hevia J, Barrera D, Jiménez-Orozco A, García-Mondragón MJ, Mendoza-Patiño N, et al. 4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility. Cancer Lett. 2003;198:179–86. Velasco-Velázquez MA, Agramonte-Hevia J, Barrera D, Jiménez-Orozco A, García-Mondragón MJ, Mendoza-Patiño N, et al. 4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility. Cancer Lett. 2003;198:179–86.
30.
Zurück zum Zitat Delamarre E, Taboubi S, Mathieu S, Bérenguer C, Rigot V, Lissitzky JC, et al. Expression of integrin alpha 6 beta1 enhances tumorigenesis in glioma cells. Am J Pathol. 2009;175:844–55. Delamarre E, Taboubi S, Mathieu S, Bérenguer C, Rigot V, Lissitzky JC, et al. Expression of integrin alpha 6 beta1 enhances tumorigenesis in glioma cells. Am J Pathol. 2009;175:844–55.
32.
Zurück zum Zitat Kielbus M, Skalicka-Wozniak K, Grabarska A, Jeleniewicz W, Dmoszynska-Graniczka M, Marston A, et al. 7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro. Anticancer Res. 2013;33:4347–56. Kielbus M, Skalicka-Wozniak K, Grabarska A, Jeleniewicz W, Dmoszynska-Graniczka M, Marston A, et al. 7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro. Anticancer Res. 2013;33:4347–56.
33.
Zurück zum Zitat Lü HQ, Niggemann B, Zänker KS. Suppression of the proliferation and migration of oncogenic ras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules. J Cancer Res Clin Oncol. 1996;122:335–42.CrossRefPubMed Lü HQ, Niggemann B, Zänker KS. Suppression of the proliferation and migration of oncogenic ras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules. J Cancer Res Clin Oncol. 1996;122:335–42.CrossRefPubMed
34.
Zurück zum Zitat Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta. 2004;1654:13–22.PubMed Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta. 2004;1654:13–22.PubMed
35.
Zurück zum Zitat Cheng TM, Murad YM, Chang CC, Yang MC, Baral TN, Cowan A, et al. Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells. Eur J Cancer. 2014;50:713–21. Cheng TM, Murad YM, Chang CC, Yang MC, Baral TN, Cowan A, et al. Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells. Eur J Cancer. 2014;50:713–21.
36.
Zurück zum Zitat Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 2001;154:1069–79. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 2001;154:1069–79.
37.
Zurück zum Zitat Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, et al. Deletion of the laminin a4 chain leads to impaired microvessel maturation. Mol Cell Biol. 2002;22:1194–202. Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, et al. Deletion of the laminin a4 chain leads to impaired microvessel maturation. Mol Cell Biol. 2002;22:1194–202.
38.
Zurück zum Zitat Nam NH, Kim Y, You YJ, Hong DH, Kim HM, Ahn BZ. Preliminary structure antiangiogenic activity relationships of 4-senecioyloxymethyl-6,7-dimethoxycoumarin. Bioorg Med Chem Lett. 2002;12:2345–8.CrossRefPubMed Nam NH, Kim Y, You YJ, Hong DH, Kim HM, Ahn BZ. Preliminary structure antiangiogenic activity relationships of 4-senecioyloxymethyl-6,7-dimethoxycoumarin. Bioorg Med Chem Lett. 2002;12:2345–8.CrossRefPubMed
39.
Zurück zum Zitat Lee S, Sivakumar K, Shin WS, Xie F, Wang Q. Synthesis and anti-angiogenesis activity of coumarin derivatives. Bioorg Med Chem Lett. 2006;16:4596–9.CrossRefPubMed Lee S, Sivakumar K, Shin WS, Xie F, Wang Q. Synthesis and anti-angiogenesis activity of coumarin derivatives. Bioorg Med Chem Lett. 2006;16:4596–9.CrossRefPubMed
40.
Zurück zum Zitat Vijay Avin BR, Thirusangu P, Lakshmi Ranganatha V, Firdouse A, Prabhakar BT, Khanum SA. Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis. Eur J Med Chem. 2014;75:211–21. Vijay Avin BR, Thirusangu P, Lakshmi Ranganatha V, Firdouse A, Prabhakar BT, Khanum SA. Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis. Eur J Med Chem. 2014;75:211–21.
41.
Zurück zum Zitat Tucher GC. Integrins: molecular targets in cancer therapy. Curr oncol Rep. 2006;8:96–103.CrossRef Tucher GC. Integrins: molecular targets in cancer therapy. Curr oncol Rep. 2006;8:96–103.CrossRef
42.
Zurück zum Zitat Mokdad-Bzeouich I, Mustapha N, Chaabane F, Ghedira Z, Ghedira K, Ghoul M, et al. Oligomerization of esculin improves its antibacterial activity and modulates antibiotic resistance. J Antibiot (Tokyo). 2015;68:148–5. Mokdad-Bzeouich I, Mustapha N, Chaabane F, Ghedira Z, Ghedira K, Ghoul M, et al. Oligomerization of esculin improves its antibacterial activity and modulates antibiotic resistance. J Antibiot (Tokyo). 2015;68:148–5.
Metadaten
Titel
Esculin and its oligomer fractions inhibit adhesion and migration of U87 glioblastoma cells and in vitro angiogenesis
verfasst von
Imen Mokdad-Bzeouich
Hervé Kovacic
Kamel Ghedira
Latifa Chebil
Mohamed Ghoul
Leila Chekir-Ghedira
José Luis
Publikationsdatum
12.10.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 3/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4209-1

Weitere Artikel der Ausgabe 3/2016

Tumor Biology 3/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.